[Vascular depression in the elderly. Does inflammation play a role?]

Recenti Prog Med. 2011 Jun;102(6):261-6. doi: 10.1701/893.9844.
[Article in Italian]

Abstract

Vascular depression in the elderly. Does inflammation play a role?Depression is the most common comorbidity in the elderly, and it is a major determinant of disability. The late-onset depression in highly associated to cardiovascular disease. Depressive symptoms may follow vascular brain damage, especially when mood regulating areas are affected. However depression is strongly associated to vascular disease even when there is no manifest brain damage. Recently great attention has been given to chronic inflammation, both related to depression and vascular disease. Both experimental and clinical evidence shows that a rise in the concentrations of proinflammatory cytokines and glucocorticoids in depressed patients is associated with defect in serotonergic function. Chronic inflammation may underlie many forms of depression associated with vascular disease and metabolic syndrome. The importance of the inflammation hypothesis of depression lies is that psychotropic drugs may have central anti-inflammatory action, and that new generation of central anti-inflammatory drugs may be useful in depression treatment.

Publication types

  • Editorial

MeSH terms

  • Aged
  • Aging*
  • Anti-Inflammatory Agents / therapeutic use*
  • Atherosclerosis / complications
  • Atherosclerosis / physiopathology
  • Body Mass Index
  • Brain / blood supply
  • Brain / metabolism
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / physiopathology
  • Cytokines / metabolism
  • Depressive Disorder / drug therapy
  • Depressive Disorder / etiology*
  • Depressive Disorder / metabolism
  • Depressive Disorder / physiopathology*
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Glucocorticoids / metabolism
  • Humans
  • Inflammation / complications*
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Inflammation / physiopathology*
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / physiopathology
  • Psychotropic Drugs / therapeutic use
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Glucocorticoids
  • Psychotropic Drugs